Status | Study |
Completed |
Study Name: Study for the RevLite Laser System for Facial Solar Lentigines Condition: Facial Solar Lentigines Date: 2014-04-08 Interventions: Device: Revlite Laser System Revlite Laser System for the Treatment of Facial Solar Lentigines |
Completed |
Study Name: Laser Removal of Age (Sun) Spots on Hands Condition: Solar Lentigines Date: 2013-06-21 Interventions: Device: Picosecond QS Nd:YAG Laser Up to 2 laser treatments delivered 6 weeks apart |
Completed |
Study Name: A Fixed Triple Combination Cream for Solar Lentigines Associated to Cryotherapy Condition: Solar Lentigines Date: 2013-01-04 Interventions: Drug: Tri-luma |
Recruiting |
Study Name: Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face Condition: Lentigo Maligna Melanoma (Head or Neck) Date: 2012-10-23 Interventions: Drug: Imiquimod cream + surgery |
Completed |
Study Name: Evaluate the Lightening Effect of the Whitening Cosmetic Product BEX-2011 Condition: Solar Lentigines Date: 2010-11-25 Interventions: Other: skin whitening cosmetic product Product application: twice a day in the morning and before sleep |
Completed |
Study Name: Effect of Topical Imiquimod on Lentigo Maligna Condition: Lentigo Maligna Date: 2010-06-24 Interventions: Drug: Imiquimod 250mg sachets to be applied at a start dose of 5 days a week. Dose will be adjusted usin |
Completed |
Study Name: Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion Condition: Lentigo Melasma Date: 2010-06-02 |
Terminated |
Study Name: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma Condition: Acral Lentiginous Malignant Melanoma Lentigo Maligna Malignant Date: 2010-05-07 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Recruiting |
Study Name: Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna Condition: Lentigo Maligna Date: 2010-03-16 Interventions: Drug: Imiquimod Imiquimod 5% cream is applied once daily. Each patient will begin with the application 3 |
Completed |
Study Name: Solar Lentigines Treatment With the Triple Combination Cream Condition: Lentigo Date: 2009-09-10 Interventions: Drug: Triple combination cream |